eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



bevacizumab
Avastin Pharmaceutical company:
Genentech, Inc.
www.avastin.com

NEW INDICATION & DOSAGE
With paclitaxel, for the treatment of patients who haven’t received chemotherapy for metastatic HER2 negative breast cancer--
Adults: 10 mg/kg I.V. infusion once every 14 days.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins